{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:44:02Z","timestamp":1792122242035,"version":"4.4.0"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"crossref","award":["2023YFS0086"],"award-info":[{"award-number":["2023YFS0086"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00277-025-06241-0","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T10:52:32Z","timestamp":1738925552000},"page":"895-912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Single-cell sequencing reveals the mechanisms of multiple myeloma progression: clarity or confusion?"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6999-6377","authenticated-orcid":false,"given":"Yunhui","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8253-8768","authenticated-orcid":false,"given":"Guokang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lvbo","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7847-7552","authenticated-orcid":false,"given":"Pinpin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5482-2304","authenticated-orcid":false,"given":"Chunbao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"6241_CR1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3389\/fimmu.2019.01121","volume":"10","author":"BG Barwick","year":"2019","unstructured":"Barwick BG, Gupta VA, Vertino PM, Boise LH (2019) Cell of origin and genetic alterations in the pathogenesis of multiple myeloma. Front Immunol 10:1121. https:\/\/doi.org\/10.3389\/fimmu.2019.01121","journal-title":"Front Immunol"},{"issue":"23","key":"6241_CR2","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1182\/blood-2016-09-692954","volume":"128","author":"MV Dhodapkar","year":"2016","unstructured":"Dhodapkar MV (2016) MGUS to myeloma: a mysterious gammopathy of underexplored significance. Blood 128(23):2599\u20132606. https:\/\/doi.org\/10.1182\/blood-2016-09-692954","journal-title":"Blood"},{"issue":"3","key":"6241_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nri3795","volume":"15","author":"SL Nutt","year":"2015","unstructured":"Nutt SL, Hodgkin PD, Tarlinton DM, Corcoran LM (2015) The generation of antibody-secreting plasma cells. Nat Rev Immunol 15(3):160\u2013171. https:\/\/doi.org\/10.1038\/nri3795","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"6241_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nrclinonc.2016.122","volume":"14","author":"S Manier","year":"2017","unstructured":"Manier S, Salem KZ, Park J, Landau DA, Getz G, Ghobrial IM (2017) Genomic complexity of multiple myeloma and its clinical implications. Nat Reviews Clin Oncol 14(2):100\u2013113. https:\/\/doi.org\/10.1038\/nrclinonc.2016.122","journal-title":"Nat Reviews Clin Oncol"},{"issue":"9","key":"6241_CR5","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1182\/blood-2007-02-069625","volume":"110","author":"D Gonz\u00e1lez","year":"2007","unstructured":"Gonz\u00e1lez D, van der Burg M, Garc\u00eda-Sanz R, Fenton JA, Langerak AW, Gonz\u00e1lez M, Morgan GJ (2007) Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma. Blood 110(9):3112\u20133121. https:\/\/doi.org\/10.1182\/blood-2007-02-069625","journal-title":"Blood"},{"issue":"1","key":"6241_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2005-01-0034","volume":"106","author":"PL Bergsagel","year":"2005","unstructured":"Bergsagel PL, Kuehl WM, Zhan F, Sawyer J, Barlogie B, Shaughnessy J (2005) Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood 106(1):296\u2013303. https:\/\/doi.org\/10.1182\/blood-2005-01-0034","journal-title":"Blood"},{"key":"6241_CR7","doi-asserted-by":"publisher","unstructured":"Cardona-Benavides IJ, Misiewicz-Krzeminska I, Rojas EA, De Ram\u00f3n C, Sanz-Solas A, Isidro I, Guti\u00e9rrez NC (2023) Quantification of cyclin D1 and D2 proteins in multiple myeloma identifies different expression patterns from those revealed by gene expression profiling. Haematologica 877\u2013887. https:\/\/doi.org\/10.3324\/haematol.2023.283445","DOI":"10.3324\/haematol.2023.283445"},{"key":"6241_CR8","doi-asserted-by":"publisher","unstructured":"Mikulasova A, Morgan GJ, Walker BA (2022) Chromosomal abnormalities in multiple myeloma. Nat Reviews Disease Primers 8(1) 42, s41572-022-00374\u20136. https:\/\/doi.org\/10.1038\/s41572-022-00374-6","DOI":"10.1038\/s41572-022-00374-6"},{"issue":"5","key":"6241_CR9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1182\/blood-2014-07-584268","volume":"125","author":"C Pawlyn","year":"2015","unstructured":"Pawlyn C, Melchor L, Murison A, Wardell CP, Brioli A, Boyle EM, Morgan GJ (2015) Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocations. Blood 125(5):831\u2013840. https:\/\/doi.org\/10.1182\/blood-2014-07-584268","journal-title":"Blood"},{"issue":"13","key":"6241_CR10","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1182\/bloodadvances.2018028530","volume":"3","author":"A Lakshman","year":"2019","unstructured":"Lakshman A, Painuly U, Rajkumar SV, Ketterling RP, Kapoor P, Greipp PT, Kumar SK (2019) Impact of acquired Del(17p) in multiple myeloma. Blood Adv 3(13):1930\u20131938. https:\/\/doi.org\/10.1182\/bloodadvances.2018028530","journal-title":"Blood Adv"},{"issue":"Supplement 1","key":"6241_CR11","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1182\/blood-2021-152794","volume":"138","author":"Y Yan","year":"2021","unstructured":"Yan Y, Qin X, Liu J, Fan H, Liu L, Yu Z, An G (2021) Clonal heterogeneity and evolutionary phylogeny of critical cytogenetic aberrations in multiple myeloma. Blood 138(Supplement 1):1608\u20131608. https:\/\/doi.org\/10.1182\/blood-2021-152794","journal-title":"Blood"},{"issue":"7201","key":"6241_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature07064","volume":"454","author":"AL Shaffer","year":"2008","unstructured":"Shaffer AL, Emre NCT, Lamy L, Ngo VN, Wright G, Xiao W, Staudt LM (2008) IRF4 addiction in multiple myeloma. Nature 454(7201):226\u2013231. https:\/\/doi.org\/10.1038\/nature07064","journal-title":"Nature"},{"issue":"8","key":"6241_CR13","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1182\/blood.2020005288","volume":"136","author":"PM Voorhees","year":"2020","unstructured":"Voorhees PM, Kaufman JL, Laubach J, Sborov DW, Reeves B, Rodriguez C, Richardson PG (2020) Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial. Blood 136(8):936\u2013945. https:\/\/doi.org\/10.1182\/blood.2020005288","journal-title":"Blood"},{"key":"6241_CR14","doi-asserted-by":"publisher","unstructured":"Attal M, Lauwers-Cances V, Hulin C, Leleu X, Caillot D, Escoffre M\u2026 IFM 2009 study. (2017). Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma. N Engl J Med, 376(14), 1311\u20131320. https:\/\/doi.org\/10.1056\/NEJMoa1611750","DOI":"10.1056\/NEJMoa1611750"},{"issue":"5","key":"6241_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, Libby EN (2022) Diagnosis and management of multiple myeloma: a review. JAMA 327(5):464. https:\/\/doi.org\/10.1001\/jama.2022.0003","journal-title":"JAMA"},{"issue":"18","key":"6241_CR16","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","volume":"380","author":"N Raje","year":"2019","unstructured":"Raje N, Berdeja J, Lin Y, Siegel D, Jagannath S, Madduri D, Kochenderfer JN (2019) Anti-BCMA CAR T-Cell therapy bb2121 in relapsed or refractory multiple myeloma. N Engl J Med 380(18):1726\u20131737. https:\/\/doi.org\/10.1056\/NEJMoa1817226","journal-title":"N Engl J Med"},{"issue":"2","key":"6241_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ymthe.2023.12.018","volume":"32","author":"L Mikkilineni","year":"2024","unstructured":"Mikkilineni L, Natrakul DA, Lam N, Manasanch EE, Mann J, Weissler KA, Kochenderfer JN (2024) Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain. Mol Therapy: J Am Soc Gene Therapy 32(2):503\u2013526. https:\/\/doi.org\/10.1016\/j.ymthe.2023.12.018","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"issue":"14","key":"6241_CR18","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1200\/JCO.22.01824","volume":"41","author":"J Xia","year":"2023","unstructured":"Xia J, Li H, Yan Z, Zhou D, Wang Y, Qi Y, Xu K (2023) Anti-G protein-coupled receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in patients with relapsed or refractory multiple myeloma: a Single-Arm, phase II trial. J Clin Oncology: Official J Am Soc Clin Oncol 41(14):2583\u20132593. https:\/\/doi.org\/10.1200\/JCO.22.01824","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"2","key":"6241_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1182\/blood.2024025987","volume":"145","author":"J Eckmann","year":"2025","unstructured":"Eckmann J, Fauti T, Biehl M, Zabaleta A, Blanco L, Lelios I, Uma\u00f1a P (2025) Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2\u2009+\u20091 format, for the treatment of multiple myeloma. Blood 145(2):202\u2013219. https:\/\/doi.org\/10.1182\/blood.2024025987","journal-title":"Blood"},{"issue":"8","key":"6241_CR20","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.3324\/haematol.2023.283058","volume":"109","author":"M Engelhardt","year":"2024","unstructured":"Engelhardt M, Kort\u00fcm KM, Goldschmidt H, Merz M (2024) Functional cure and long-term survival in multiple myeloma: how to challenge the previously impossible. Haematologica 109(8):2420\u20132435. https:\/\/doi.org\/10.3324\/haematol.2023.283058","journal-title":"Haematologica"},{"issue":"7341","key":"6241_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature09807","volume":"472","author":"N Navin","year":"2011","unstructured":"Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, Wigler M (2011) Tumour evolution inferred by single-cell sequencing. Nature 472(7341):90\u201394. https:\/\/doi.org\/10.1038\/nature09807","journal-title":"Nature"},{"issue":"6190","key":"6241_CR22","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Bernstein BE (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Sci (New York N Y) 344(6190):1396\u20131401. https:\/\/doi.org\/10.1126\/science.1254257","journal-title":"Sci (New York N Y)"},{"key":"6241_CR23","doi-asserted-by":"publisher","unstructured":"Melchor L, Brioli A, Wardell CP, Murison A, Potter NE, Kaiser MF, Morgan GJ (2013) Single-cell genetic analysis reveals the genetic composition of founder clones, phylogenetic patterns of branching and parallel evolution, and clonal fluctuations following patient treatment in multiple myeloma. Blood 122(21):398\u2013398. https:\/\/doi.org\/10.1182\/blood.V122.21.398.398","DOI":"10.1182\/blood.V122.21.398.398"},{"issue":"21","key":"6241_CR24","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1182\/blood.V124.21.3385.3385","volume":"124","author":"AK Mitra","year":"2014","unstructured":"Mitra AK, Stessman H, Linden MA, Van Ness B (2014) Single-cell Transcriptomics identifies Intra-tumor Heterogeneity in Human Myeloma Cell lines. Blood 124(21):3385\u20133385. https:\/\/doi.org\/10.1182\/blood.V124.21.3385.3385","journal-title":"Blood"},{"issue":"5","key":"6241_CR25","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/leu.2015.361","volume":"30","author":"AK Mitra","year":"2016","unstructured":"Mitra AK, Mukherjee UK, Harding T, Jang JS, Stessman H, Li Y, Van Ness B (2016) Single-cell analysis of targeted transcriptome predicts drug sensitivity of single cells within human myeloma tumors. Leukemia 30(5):1094\u20131102. https:\/\/doi.org\/10.1038\/leu.2015.361","journal-title":"Leukemia"},{"issue":"5","key":"6241_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nmeth.1315","volume":"6","author":"F Tang","year":"2009","unstructured":"Tang F, Barbacioru C, Wang Y, Nordman E, Lee C, Xu N, Surani MA (2009) mRNA-Seq whole-transcriptome analysis of a single cell. Nat Methods 6(5):377\u2013382. https:\/\/doi.org\/10.1038\/nmeth.1315","journal-title":"Nat Methods"},{"issue":"10","key":"6241_CR27","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1101\/gr.191098.115","volume":"25","author":"NE Navin","year":"2015","unstructured":"Navin NE (2015) The first five years of single-cell cancer genomics and beyond. Genome Res 25(10):1499\u20131507. https:\/\/doi.org\/10.1101\/gr.191098.115","journal-title":"Genome Res"},{"issue":"7","key":"6241_CR28","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1101\/gr.110882.110","volume":"21","author":"S Islam","year":"2011","unstructured":"Islam S, Kj\u00e4llquist U, Moliner A, Zajac P, Fan J-B, L\u00f6nnerberg P, Linnarsson S (2011) Characterization of the single-cell transcriptional landscape by highly multiplex RNA-seq. Genome Res 21(7):1160\u20131167. https:\/\/doi.org\/10.1101\/gr.110882.110","journal-title":"Genome Res"},{"issue":"Supplement 1","key":"6241_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1182\/blood-2020-142205","volume":"136","author":"L Yao","year":"2020","unstructured":"Yao L, Jayasinghe RG, Wang T, O\u2019Neal J, Liu R, Rettig MP, DiPersio JF (2020) Myeloma Cell Associated Therapeutic Protein Discovery using single cell RNA-Seq Data. Blood 136(Supplement 1):4\u20135. https:\/\/doi.org\/10.1182\/blood-2020-142205","journal-title":"Blood"},{"issue":"8","key":"6241_CR30","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nmeth.3035","volume":"11","author":"SA Smallwood","year":"2014","unstructured":"Smallwood SA, Lee HJ, Angermueller C, Krueger F, Saadeh H, Peat J, Kelsey G (2014) Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity. Nat Methods 11(8):817\u2013820. https:\/\/doi.org\/10.1038\/nmeth.3035","journal-title":"Nat Methods"},{"issue":"5","key":"6241_CR31","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cell.2015.05.002","volume":"161","author":"EZ Macosko","year":"2015","unstructured":"Macosko EZ, Basu A, Satija R, Nemesh J, Shekhar K, Goldman M, McCarroll SA (2015) Highly parallel genome-wide expression profiling of individual cells using Nanoliter droplets. Cell 161(5):1202\u20131214. https:\/\/doi.org\/10.1016\/j.cell.2015.05.002","journal-title":"Cell"},{"issue":"6114","key":"6241_CR32","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1126\/science.1229164","volume":"338","author":"C Zong","year":"2012","unstructured":"Zong C, Lu S, Chapman AR, Xie XS (2012) Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Sci (New York N Y) 338(6114):1622\u20131626. https:\/\/doi.org\/10.1126\/science.1229164","journal-title":"Sci (New York N Y)"},{"key":"6241_CR33","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/S2152-2650(21)02195-9","volume":"21","author":"N Ansari-Pour","year":"2021","unstructured":"Ansari-Pour N, Salatino S, Weston-Bell N, Bryant D, Moreno LY, Vacca A, Sahota S (2021) Single-cell whole-exome DNA sequencing traces clonal trajectory in paired evolution of MGUS to multiple myeloma. Clin Lymphoma Myeloma Leuk 21:S72. https:\/\/doi.org\/10.1016\/S2152-2650(21)02195-9","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"6241_CR34","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.molcel.2020.09.025","volume":"80","author":"V Zachariadis","year":"2020","unstructured":"Zachariadis V, Cheng H, Andrews N, Enge M (2020) A highly scalable method for joint whole-genome sequencing and gene-expression profiling of single cells. Mol Cell 80(3):541\u2013553e5. https:\/\/doi.org\/10.1016\/j.molcel.2020.09.025","journal-title":"Mol Cell"},{"issue":"10","key":"6241_CR35","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/s41587-023-01676-0","volume":"41","author":"Y Liu","year":"2023","unstructured":"Liu Y, DiStasio M, Su G, Asashima H, Enninful A, Qin X, Fan R (2023) High-plex protein and whole transcriptome co-mapping at cellular resolution with spatial CITE-seq. Nat Biotechnol 41(10):1405\u20131409. https:\/\/doi.org\/10.1038\/s41587-023-01676-0","journal-title":"Nat Biotechnol"},{"issue":"Supplement 1","key":"6241_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1182\/blood-2020-143256","volume":"136","author":"RG Jayasinghe","year":"2020","unstructured":"Jayasinghe RG, Yao L, Thomas B, Bhasin SS, Fernandez N, Avigan DE, Ding L (2020) Identification and validation of CD138- multiple myeloma Immune and Tumor subpopulations using Cross Center Scrna-Seq Data. Blood 136(Supplement 1):15\u201315. https:\/\/doi.org\/10.1182\/blood-2020-143256","journal-title":"Blood"},{"issue":"7","key":"6241_CR37","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nbt.2938","volume":"32","author":"A Han","year":"2014","unstructured":"Han A, Glanville J, Hansmann L, Davis MM (2014) Linking T-cell receptor sequence to functional phenotype at the single-cell level. Nat Biotechnol 32(7):684\u2013692. https:\/\/doi.org\/10.1038\/nbt.2938","journal-title":"Nat Biotechnol"},{"issue":"8","key":"6241_CR38","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1038\/s41596-019-0195-x","volume":"14","author":"S Li","year":"2019","unstructured":"Li S, Sun J, Alles\u00f8e R, Datta K, Bao Y, Oliveira G, Livak KJ (2019) RNase H-dependent PCR-enabled T-cell receptor sequencing for highly specific and efficient targeted sequencing of T-cell receptor mRNA for single-cell and repertoire analysis. Nat Protoc 14(8):2571\u20132594. https:\/\/doi.org\/10.1038\/s41596-019-0195-x","journal-title":"Nat Protoc"},{"issue":"7","key":"6241_CR39","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.cell.2019.11.003","volume":"179","author":"I Setliff","year":"2019","unstructured":"Setliff I, Shiakolas AR, Pilewski KA, Murji AA, Mapengo RE, Janowska K, Georgiev IS (2019) High-throughput mapping of B cell receptor sequences to Antigen specificity. Cell 179(7):1636\u20131646e15. https:\/\/doi.org\/10.1016\/j.cell.2019.11.003","journal-title":"Cell"},{"issue":"1","key":"6241_CR40","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s42003-024-06823-0","volume":"7","author":"DM Morgan","year":"2024","unstructured":"Morgan DM, Zhang YJ, Kim J-H, Murillo M, Singh S, Loschko J, Christopher Love J (2024) Full-length single-cell BCR sequencing paired with RNA sequencing reveals convergent responses to pneumococcal vaccination. Commun Biology 7(1):1208. https:\/\/doi.org\/10.1038\/s42003-024-06823-0","journal-title":"Commun Biology"},{"key":"6241_CR41","doi-asserted-by":"publisher","first-page":"e45105","DOI":"10.7554\/eLife.45105","volume":"8","author":"J Xu","year":"2019","unstructured":"Xu J, Nuno K, Litzenburger UM, Qi Y, Corces MR, Majeti R, Chang HY (2019) Single-cell lineage tracing by endogenous mutations enriched in transposase accessible mitochondrial DNA. eLife 8:e45105. https:\/\/doi.org\/10.7554\/eLife.45105","journal-title":"eLife"},{"issue":"6","key":"6241_CR42","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/s41596-022-00692-9","volume":"17","author":"FC Grandi","year":"2022","unstructured":"Grandi FC, Modi H, Kampman L, Corces MR (2022) Chromatin accessibility profiling by ATAC-seq. Nat Protoc 17(6):1518\u20131552. https:\/\/doi.org\/10.1038\/s41596-022-00692-9","journal-title":"Nat Protoc"},{"issue":"19","key":"6241_CR43","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1182\/blood.2023019758","volume":"142","author":"AM Poos","year":"2023","unstructured":"Poos AM, Prokoph N, Przybilla MJ, Mallm J-P, Steiger S, Seufert I, Weinhold N (2023) Resolving therapy resistance mechanisms in multiple myeloma by multi-omics subclone analysis. Blood 142(19):1633\u20131646. https:\/\/doi.org\/10.1182\/blood.2023019758","journal-title":"Blood"},{"issue":"9","key":"6241_CR44","doi-asserted-by":"publisher","first-page":"8422","DOI":"10.3390\/ijms24098422","volume":"24","author":"M-I Christodoulou","year":"2023","unstructured":"Christodoulou M-I, Zaravinos A (2023) Single-cell analysis in Immuno-Oncology. Int J Mol Sci 24(9):8422. https:\/\/doi.org\/10.3390\/ijms24098422","journal-title":"Int J Mol Sci"},{"issue":"23","key":"6241_CR45","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1182\/blood.V126.23.4808.4808","volume":"126","author":"S Geng","year":"2015","unstructured":"Geng S, Wang J, Chen M, Wang W, Pang Y, Liu Y, Jing H (2015) Single cell RNA-Seq reveals clonal consistency and Differential Malignancy in Extramedullary Plasmacytoma of multiple myeloma. Blood 126(23):4808\u20134808. https:\/\/doi.org\/10.1182\/blood.V126.23.4808.4808","journal-title":"Blood"},{"issue":"22","key":"6241_CR46","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1182\/blood.V128.22.5651.5651","volume":"128","author":"D Bryant","year":"2016","unstructured":"Bryant D, Tapper W, Weston-Bell NJ, Bolomsky A, Song L, Xu S, Sahota SS (2016) Single cell whole exome sequencing in an Index Case of Amp1q21 multiple myeloma to define Intraclonal Variation. Blood 128(22):5651\u20135651. https:\/\/doi.org\/10.1182\/blood.V128.22.5651.5651","journal-title":"Blood"},{"issue":"Supplement1","key":"6241_CR47","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1182\/blood-2019-130051","volume":"134","author":"AM Poos","year":"2019","unstructured":"Poos AM, Mallm J-P, Tirier SM, Casiraghi N, Susak H, Giesen N, Weinhold N (2019) A comprehensive analysis of single-cell chromatin accessibility and gene expression identifies Intra-tumor heterogeneity and molecular treatment responses in Relapsed\/Refractory multiple myeloma. Blood 134(Supplement1):575\u2013575. https:\/\/doi.org\/10.1182\/blood-2019-130051","journal-title":"Blood"},{"key":"6241_CR48","doi-asserted-by":"publisher","first-page":"663487","DOI":"10.3389\/fgene.2021.663487","volume":"12","author":"D Chen","year":"2021","unstructured":"Chen D, Abu Zaid MI, Reiter JL, Czader M, Wang L, McGuire P, Liu Y (2021) Cryopreservation preserves cell-type composition and gene expression profiles in bone marrow aspirates from multiple myeloma patients. Front Genet 12:663487. https:\/\/doi.org\/10.3389\/fgene.2021.663487","journal-title":"Front Genet"},{"issue":"5","key":"6241_CR49","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s43018-020-0053-3","volume":"1","author":"O Zavidij","year":"2020","unstructured":"Zavidij O, Haradhvala NJ, Mouhieddine TH, Sklavenitis-Pistofidis R, Cai S, Reidy M, Ghobrial IM (2020) Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma. Nat Cancer 1(5):493\u2013506. https:\/\/doi.org\/10.1038\/s43018-020-0053-3","journal-title":"Nat Cancer"},{"issue":"12","key":"6241_CR50","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1038\/s41591-018-0269-2","volume":"24","author":"G Ledergor","year":"2018","unstructured":"Ledergor G, Weiner A, Zada M, Wang S-Y, Cohen YC, Gatt ME, Amit I (2018) Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma. Nat Med 24(12):1867\u20131876. https:\/\/doi.org\/10.1038\/s41591-018-0269-2","journal-title":"Nat Med"},{"issue":"8","key":"6241_CR51","doi-asserted-by":"publisher","first-page":"706","DOI":"10.4252\/wjsc.v12.i8.706","volume":"12","author":"LX Lee","year":"2020","unstructured":"Lee LX, Li SC (2020) Hunting down the dominating subclone of cancer stem cells as a potential new therapeutic target in multiple myeloma: an artificial intelligence perspective. World J Stem Cells 12(8):706\u2013720. https:\/\/doi.org\/10.4252\/wjsc.v12.i8.706","journal-title":"World J Stem Cells"},{"key":"6241_CR52","doi-asserted-by":"publisher","unstructured":"Mehr S, Auclair D, Hamilton M, Rozenblit L, Cho HJ, Yao L, Miron S (2020) Blood 136(Supplement 1):17\u201318. https:\/\/doi.org\/10.1182\/blood-2020-142882. Architecture of Sample Preparation and Data Governance of Immuno-Genomic Data Collected from Bone Marrow and Peripheral Blood Samples Obtained from Multiple Myeloma Patients","DOI":"10.1182\/blood-2020-142882"},{"issue":"6","key":"6241_CR53","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/nprot.2018.021","volume":"13","author":"P Chovanec","year":"2018","unstructured":"Chovanec P, Bolland DJ, Matheson LS, Wood AL, Krueger F, Andrews S, Corcoran AE (2018) Unbiased quantification of immunoglobulin diversity at the DNA level with VDJ-seq. Nat Protoc 13(6):1232\u20131252. https:\/\/doi.org\/10.1038\/nprot.2018.021","journal-title":"Nat Protoc"},{"issue":"7","key":"6241_CR54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41408-020-00343-w","volume":"10","author":"M Hultcrantz","year":"2020","unstructured":"Hultcrantz M, Rustad EH, Yellapantula V, Arcila M, Ho C, Syed MH, Landgren O (2020) Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment. Blood Cancer J 10(7):76. https:\/\/doi.org\/10.1038\/s41408-020-00343-w","journal-title":"Blood Cancer J"},{"issue":"24","key":"6241_CR55","doi-asserted-by":"publisher","first-page":"15691","DOI":"10.3390\/ijms232415691","volume":"23","author":"A Matera","year":"2022","unstructured":"Matera A, Marella A, Maeda A, Da Vi\u00e0 MC, Lazzaroni F, Fabris S, Lionetti M (2022) Single-cell RNA sequencing for the detection of clonotypic V(D)J rearrangements in multiple myeloma. Int J Mol Sci 23(24):15691. https:\/\/doi.org\/10.3390\/ijms232415691","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6241_CR56","doi-asserted-by":"publisher","first-page":"e757","DOI":"10.1002\/ctm2.757","volume":"12","author":"H He","year":"2022","unstructured":"He H, Li Z, Lu J, Qiang W, Jiang S, Xu Y, Du J (2022) Single-cell RNA-seq reveals clonal diversity and prognostic genes of relapsed multiple myeloma. Clin Translational Med 12(3):e757. https:\/\/doi.org\/10.1002\/ctm2.757","journal-title":"Clin Translational Med"},{"issue":"Supplement1","key":"6241_CR57","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1182\/blood-2019-130452","volume":"134","author":"TS Johnson","year":"2019","unstructured":"Johnson TS, Yu CY, Dong C, Wang T, Abu Zaid MI, Abonour R, Huang K (2019) Development of a Novel Deep transfer learning Framework to Characterize Inter- and Intra-tumor Heterogeneity in Myeloma patients. Blood 134(Supplement1):3075\u20133075. https:\/\/doi.org\/10.1182\/blood-2019-130452","journal-title":"Blood"},{"issue":"6","key":"6241_CR58","doi-asserted-by":"publisher","first-page":"bbad335","DOI":"10.1093\/bib\/bbad335","volume":"24","author":"T Lei","year":"2023","unstructured":"Lei T, Chen R, Zhang S, Chen Y (2023) Self-supervised deep clustering of single-cell RNA-seq data to hierarchically detect rare cell populations. Brief Bioinform 24(6):bbad335. https:\/\/doi.org\/10.1093\/bib\/bbad335","journal-title":"Brief Bioinform"},{"key":"6241_CR59","doi-asserted-by":"publisher","unstructured":"Domanskyi S, Hakansson A, Paternostro G, Piermarocchi C (2019) Modeling disease progression in Multiple Myeloma with Hopfield networks and single-cell RNA-seq. Proceedings. IEEE International Conference on Bioinformatics and Biomedicine, 2019, 2129\u20132136. https:\/\/doi.org\/10.1109\/bibm47256.2019.8983325","DOI":"10.1109\/bibm47256.2019.8983325"},{"issue":"1","key":"6241_CR60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13073-022-01012-2","volume":"14","author":"TS Johnson","year":"2022","unstructured":"Johnson TS, Yu CY, Huang Z, Xu S, Wang T, Dong C, Zhang J (2022) Diagnostic evidence GAuge of single cells (DEGAS): a flexible deep transfer learning framework for prioritizing cells in relation to disease. Genome Med 14(1):11. https:\/\/doi.org\/10.1186\/s13073-022-01012-2","journal-title":"Genome Med"},{"key":"6241_CR61","doi-asserted-by":"publisher","unstructured":"Kumar, H., Mazumder, S., Chakravarti, S., Sharma, N., Mukherjee, U. K., Kumar, S.,\u2026 Mitra, A. K. (2022). secDrug: a pipeline to discover novel drug combinations to kill drug-resistant multiple myeloma cells using a greedy set cover algorithm and single-cell multi-omics. Blood Cancer Journal, 12(3), 39. https:\/\/doi.org\/10.1038\/s41408-022-00636-2","DOI":"10.1038\/s41408-022-00636-2"},{"issue":"1","key":"6241_CR62","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1038\/s41467-020-16434-y","volume":"11","author":"SM Foltz","year":"2020","unstructured":"Foltz SM, Gao Q, Yoon CJ, Sun H, Yao L, Li Y, Vij R (2020) Evolution and structure of clinically relevant gene fusions in multiple myeloma. Nat Commun 11(1):2666. https:\/\/doi.org\/10.1038\/s41467-020-16434-y","journal-title":"Nat Commun"},{"issue":"1","key":"6241_CR63","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41467-022-28661-6","volume":"13","author":"Z Jin","year":"2022","unstructured":"Jin Z, Huang W, Shen N, Li J, Wang X, Dong J, Xi R (2022) Single-cell gene fusion detection by scFusion. Nat Commun 13(1):1084. https:\/\/doi.org\/10.1038\/s41467-022-28661-6","journal-title":"Nat Commun"},{"issue":"3","key":"6241_CR64","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41587-022-01468-y","volume":"41","author":"T Gao","year":"2023","unstructured":"Gao T, Soldatov R, Sarkar H, Kurkiewicz A, Biederstedt E, Loh P-R, Kharchenko PV (2023) Haplotype-aware analysis of somatic copy number variations from single-cell transcriptomes. Nat Biotechnol 41(3):417\u2013426. https:\/\/doi.org\/10.1038\/s41587-022-01468-y","journal-title":"Nat Biotechnol"},{"issue":"1","key":"6241_CR65","doi-asserted-by":"publisher","first-page":"bbab413","DOI":"10.1093\/bib\/bbab413","volume":"23","author":"A Mahdipour-Shirayeh","year":"2022","unstructured":"Mahdipour-Shirayeh A, Erdmann N, Leung-Hagesteijn C, Tiedemann RE (2022) sciCNV: high-throughput paired profiling of transcriptomes and DNA copy number variations at single-cell resolution. Brief Bioinform 23(1):bbab413. https:\/\/doi.org\/10.1093\/bib\/bbab413","journal-title":"Brief Bioinform"},{"key":"6241_CR66","doi-asserted-by":"publisher","unstructured":"Jung, S.-H., Park, S.-S., Lim, J.-Y., Sohn, S. Y., Kim, N. Y., Kim, D.,\u2026 Min, C.-K.(2022). Single-cell analysis of multiple myelomas refines the molecular features of bortezomib treatment responsiveness. Experimental & Molecular Medicine, 54(11), 1967\u20131978. https:\/\/doi.org\/10.1038\/s12276-022-00884-z","DOI":"10.1038\/s12276-022-00884-z"},{"issue":"1","key":"6241_CR67","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cels.2023.12.005","volume":"15","author":"R Kousnetsov","year":"2024","unstructured":"Kousnetsov R, Bourque J, Surnov A, Fallahee I, Hawiger D (2024) Single-cell sequencing analysis within biologically relevant dimensions. Cell Syst 15(1):83\u2013103e11. https:\/\/doi.org\/10.1016\/j.cels.2023.12.005","journal-title":"Cell Syst"},{"issue":"21","key":"6241_CR68","doi-asserted-by":"publisher","first-page":"13427","DOI":"10.3390\/ijms232113427","volume":"23","author":"LJ Ndacayisaba","year":"2022","unstructured":"Ndacayisaba LJ, Rappard KE, Shishido SN, Setayesh SM, Tang G, Lin P, Kuhn P (2022) Characterization of BCMA expression in circulating Rare single cells of patients with plasma cell neoplasms. Int J Mol Sci 23(21):13427. https:\/\/doi.org\/10.3390\/ijms232113427","journal-title":"Int J Mol Sci"},{"key":"6241_CR69","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bbrc.2021.02.008","volume":"546","author":"S Hirabayashi","year":"2021","unstructured":"Hirabayashi S, Shirakawa K, Horisawa Y, Matsumoto T, Matsui H, Yamazaki H, Takaori-Kondo A (2021) APOBEC3B is preferentially expressed at the G2\/M phase of cell cycle. Biochem Biophys Res Commun 546:178\u2013184. https:\/\/doi.org\/10.1016\/j.bbrc.2021.02.008","journal-title":"Biochem Biophys Res Commun"},{"key":"6241_CR70","doi-asserted-by":"publisher","unstructured":"Liu, R., Gao, Q., Foltz, S. M., Fowles, J. S., Yao, L., Wang, J. T.,\u2026 Ding, L. (2021).Co-evolution of tumor and immune cells during progression of multiple myeloma. Nature Communications, 12(1), 2559. https:\/\/doi.org\/10.1038\/s41467-021-22804-x","DOI":"10.1038\/s41467-021-22804-x"},{"key":"6241_CR71","doi-asserted-by":"publisher","unstructured":"Wang, T., Sun, H., Cui Zhou, D., Liu, R., Yao, L., Fiala, M. A.,\u2026 Ding, L. (2019).Single-Cell Pathway Enrichment and Regulatory Profiling of Multiple Myeloma across Disease Stages. Blood, 134(Supplement_1), 364\u2013364. https:\/\/doi.org\/10.1182\/blood-2019-131361","DOI":"10.1182\/blood-2019-131361"},{"key":"6241_CR72","doi-asserted-by":"publisher","unstructured":"Raspadori, A., Forcato, C., Edoardo, P., Papadopulos, F. M., Ferrarini, A., Del Monaco,V.,\u2026 Manaresi, N. (2018). A High-Throughput Workflow for the Detection, Isolation and Genomic Analysis of Single Circulating Multiple Myeloma Cells. Blood, 132(Supplement 1), 5574\u20135574. https:\/\/doi.org\/10.1182\/blood-2018-99-112871","DOI":"10.1182\/blood-2018-99-112871"},{"key":"6241_CR73","doi-asserted-by":"publisher","first-page":"844604","DOI":"10.3389\/fgene.2022.844604","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Zhang S, Li H, Guo J, Wu D, Zhou W, Xie L (2022) Cellular Interaction Analysis Characterizing Immunosuppressive Microenvironment functions in MM Tumorigenesis from Precursor stages. Front Genet 13:844604. https:\/\/doi.org\/10.3389\/fgene.2022.844604","journal-title":"Front Genet"},{"key":"6241_CR74","doi-asserted-by":"publisher","unstructured":"Merz, M., Merz, A. M. A., Wang, J., Wei, L., Hu, Q., Belal, A.,\u2026 Hillengass, J.(2020). Prospective evaluation of spatial heterogeneity at single cell resolution in multiple myeloma. Journal of Clinical Oncology, 38(15_suppl), 8524\u20138524. https:\/\/doi.org\/10.1200\/JCO.2020.38.15_suppl.8524","DOI":"10.1200\/JCO.2020.38.15_suppl.8524"},{"key":"6241_CR75","doi-asserted-by":"publisher","unstructured":"Merz, M., Merz, A. M. A., Wang, J., Wei, L., Hu, Q., Hutson, N.,\u2026 Hillengass, J.(2022). Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma. Nature Communications, 13(1), 807. https:\/\/doi.org\/10.1038\/s41467-022-28266-z","DOI":"10.1038\/s41467-022-28266-z"},{"issue":"15","key":"6241_CR76","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1182\/bloodadvances.2022009477","volume":"7","author":"Z Sun","year":"2023","unstructured":"Sun Z, Ji J, Li Y, Cui Y, Fan L, Li J, Qu X (2023) Identification of evolutionary mechanisms of myelomatous effusion by single-cell RNA sequencing. Blood Adv 7(15):4148\u20134159. https:\/\/doi.org\/10.1182\/bloodadvances.2022009477","journal-title":"Blood Adv"},{"key":"6241_CR77","doi-asserted-by":"publisher","unstructured":"Xu, J., Yu, N., Zhao, P., Wang, F., Huang, J., Cui, Y.,\u2026 Zheng, Y. (2021). Intratumor Heterogeneity of MIF Expression Correlates With Extramedullary Involvement of Multiple Myeloma. Frontiers in oncology, 11, 694331. https:\/\/doi.org\/10.3389\/fonc.2021.694331","DOI":"10.3389\/fonc.2021.694331"},{"key":"6241_CR78","doi-asserted-by":"publisher","unstructured":"Geng, S., Wang, J., Zhang, X., Zhang, J.-J., Wu, F., Pang, Y.,\u2026 Jing, H. (2020).Single-cell RNA sequencing reveals chemokine self-feeding of myeloma cells promotes extramedullary metastasis. FEBS letters, 594(3), 452\u2013465. https:\/\/doi.org\/10.1002\/1873-3468.13623","DOI":"10.1002\/1873-3468.13623"},{"key":"6241_CR79","doi-asserted-by":"publisher","unstructured":"Ryu, D., Kim, S. J., Hong, Y., Jo, A., Kim, N., Kim, H.-J.,\u2026 Park, W.-Y. (2020).Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary Progression Affect Proliferation and Immune Evasion. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 26(4), 935\u2013944. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-0694","DOI":"10.1158\/1078-0432.CCR-19-0694"},{"issue":"3","key":"6241_CR80","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41375-023-01824-0","volume":"37","author":"AM Leipold","year":"2023","unstructured":"Leipold AM, Werner RA, D\u00fcll J, Jung P, John M, Stanojkovska E, Rasche L (2023) Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma. Leukemia 37(3):650\u2013658. https:\/\/doi.org\/10.1038\/s41375-023-01824-0","journal-title":"Leukemia"},{"key":"6241_CR81","doi-asserted-by":"publisher","first-page":"117497","DOI":"10.1016\/j.cca.2023.117497","volume":"548","author":"J Ji","year":"2023","unstructured":"Ji J, Guo R, Ma J, Cui Y, Li Y, Sun Z, Qu X (2023) Liquid extramedullary disease in multiple myeloma strongly predicts a poor prognosis and is associated with bortezomib resistance gene upregulation. Clin Chim Acta 548:117497. https:\/\/doi.org\/10.1016\/j.cca.2023.117497","journal-title":"Clin Chim Acta"},{"issue":"20","key":"6241_CR82","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1182\/blood.2024024590","volume":"144","author":"M John","year":"2024","unstructured":"John M, Helal M, Duell J, Mattavelli G, Stanojkovska E, Afrin N, Rasche L (2024) Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma. Blood 144(20):2121\u20132135. https:\/\/doi.org\/10.1182\/blood.2024024590","journal-title":"Blood"},{"key":"6241_CR83","doi-asserted-by":"publisher","unstructured":"John, L., Poos, A. M., Brobeil, A., Schinke, C., Huhn, S., Prokoph, N.,\u2026 Weinhold,N. (2023). Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level. Nature Communications, 14(1), 5011. https:\/\/doi.org\/10.1038\/s41467-023-40584-4","DOI":"10.1038\/s41467-023-40584-4"},{"issue":"15suppl","key":"6241_CR84","doi-asserted-by":"publisher","first-page":"e20013","DOI":"10.1200\/JCO.2021.39.15_suppl.e20013","volume":"39","author":"S deMel","year":"2021","unstructured":"deMel S, Scolnick J, Huo X, Soekojo C, Song F, Ooi M, Chng WJ (2021) Single cell multiomic analysis and immune cell type profiling of multiple myeloma with t(4;14). J Clin Oncol 39(15suppl):e20013\u2013e20013. https:\/\/doi.org\/10.1200\/JCO.2021.39.15_suppl.e20013","journal-title":"J Clin Oncol"},{"key":"6241_CR85","doi-asserted-by":"publisher","unstructured":"Chen, M., Wan, Y., Li, X., Xiang, J., Chen, X., Jiang, J.,\u2026 Hou, J. (2023). Dynamic single-cell RNA-seq analysis reveals distinct tumor program associated with microenvironmental remodeling and drug sensitivity in multiple myeloma. Cell & Bioscience, 13, 19. https:\/\/doi.org\/10.1186\/s13578-023-00971-2","DOI":"10.1186\/s13578-023-00971-2"},{"key":"6241_CR86","doi-asserted-by":"publisher","unstructured":"Melchor, L., Brioli, A., Wardell, C. P., Murison, A., Potter, N. E., Kaiser, M. F.,\u2026 Morgan, G. J. (2014). Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma. Leukemia, 28(8), 1705\u20131715. https:\/\/doi.org\/10.1038\/leu.2014.13","DOI":"10.1038\/leu.2014.13"},{"key":"6241_CR87","doi-asserted-by":"publisher","unstructured":"He, H., Li, Z., Lu, J., Qiang, W., Jiang, S., Xu, Y.,\u2026 Du, J. (2022). Single-cell RNA-seq reveals clonal diversity and prognostic genes of relapsed multiple myeloma.Clinical and Translational Medicine, 12(3), e757. https:\/\/doi.org\/10.1002\/ctm2.757","DOI":"10.1002\/ctm2.757"},{"issue":"Supplement 1","key":"6241_CR88","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1182\/blood-2021-149701","volume":"138","author":"YC Cohen","year":"2021","unstructured":"Cohen YC, Zada M, Wang S-Y, Bentur OS, Chubar E, Cohen A, Amit I (2021) Single cell RNA sequencing in patients enrolled in a Selinexor Clinical Trial reveals overexpression of Alternative Nuclear Export pathways Associated with Resistance to Selinexor in Refractory multiple myeloma. Blood 138(Supplement 1):2725\u20132725. https:\/\/doi.org\/10.1182\/blood-2021-149701","journal-title":"Blood"},{"issue":"1","key":"6241_CR89","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/leu.2008.259","volume":"23","author":"K Podar","year":"2009","unstructured":"Podar K, Chauhan D, Anderson KC (2009) Bone marrow microenvironment and the identification of new targets for myeloma therapy. Leukemia 23(1):10\u201324. https:\/\/doi.org\/10.1038\/leu.2008.259","journal-title":"Leukemia"},{"key":"6241_CR90","doi-asserted-by":"publisher","unstructured":"Hasanali, Z. S., Garfall, A. L., Burzenski, L., Shultz, L. D., Tang, Y., Kadu, S.,\u2026 Allman, D. (2024). Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice. JCI insight, e177300. https:\/\/doi.org\/10.1172\/jci.insight.177300","DOI":"10.1172\/jci.insight.177300"},{"issue":"11","key":"6241_CR91","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3390\/biom13111629","volume":"13","author":"NS Sharma","year":"2023","unstructured":"Sharma NS, Choudhary B (2023) Good cop, bad cop: profiling the Immune Landscape in multiple myeloma. Biomolecules 13(11):1629. https:\/\/doi.org\/10.3390\/biom13111629","journal-title":"Biomolecules"},{"key":"6241_CR92","doi-asserted-by":"publisher","unstructured":"Tirier, S. M., Mallm, J.-P., Steiger, S., Poos, A. M., Awwad, M. H. S., Giesen, N.,\u2026 Rippe, K. (2021). Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics. Nature Communications, 12(1), 6960. https:\/\/doi.org\/10.1038\/s41467-021-26951-z","DOI":"10.1038\/s41467-021-26951-z"},{"key":"6241_CR93","doi-asserted-by":"publisher","unstructured":"Tirier, S. M., Mallm, J.-P., Casiraghi, N., Susak, H., Giesen, N., Poos, A. M.,\u2026Raab, M. S. (2019). Dissecting Heterogeneity of Tumor Cells and Their Microenvironment in Refractory Multiple Myeloma. Blood, 134, 571. https:\/\/doi.org\/10.1182\/blood-2019-128625","DOI":"10.1182\/blood-2019-128625"},{"key":"6241_CR94","doi-asserted-by":"publisher","unstructured":"Liang, Y., He, H., Wang, W., Wang, H., Mo, S., Fu, R.,\u2026 Wang, L. (2022). Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming. Molecular Cancer, 21(1), 182. https:\/\/doi.org\/10.1186\/s12943-022-01648-z","DOI":"10.1186\/s12943-022-01648-z"},{"key":"6241_CR95","doi-asserted-by":"publisher","unstructured":"Pilcher, W., Thomas, B. E., Bhasin, S. S., Jayasinghe, R. G., Yao, L., Gonzalez-Kozlova,E.,\u2026 Bhasin, M. (2023). Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myeloma. NPJ genomic medicine, 8(1), 3. https:\/\/doi.org\/10.1038\/s41525-022-00340-x","DOI":"10.1038\/s41525-022-00340-x"},{"key":"6241_CR96","doi-asserted-by":"publisher","unstructured":"Lv, J., Sun, H., Gong, L., Wei, X., He, Y., Yu, Z.,\u2026 Hao, M. (2022). Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma. Frontiers in Immunology, 13, 1077768. https:\/\/doi.org\/10.3389\/fimmu.2022.1077768","DOI":"10.3389\/fimmu.2022.1077768"},{"key":"6241_CR97","doi-asserted-by":"publisher","unstructured":"Li, W., Zhang, B., Cao, W., Zhang, W., Li, T., Liu, L.,\u2026 Song, Y. (2023). Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed\/refractory multiple myeloma through single-cell sequencing.Experimental hematology & oncology, 12(1), 44. https:\/\/doi.org\/10.1186\/s40164-023-00402-5","DOI":"10.1186\/s40164-023-00402-5"},{"key":"6241_CR98","doi-asserted-by":"publisher","unstructured":"Li, J., Yang, Y., Wang, W., Xu, J., Sun, Y., Jiang, J.,\u2026 Liu, P. (2023). Single-cell atlas of the immune microenvironment reveals macrophage reprogramming and the potential dual macrophage-targeted strategy in multiple myeloma. British Journal of Haematology, 201(5), 917\u2013934. https:\/\/doi.org\/10.1111\/bjh.18708","DOI":"10.1111\/bjh.18708"},{"key":"6241_CR99","doi-asserted-by":"publisher","unstructured":"Jiang, J., Xiang, J., Chen, M., Wan, Y., Zhong, L., Han, X.,\u2026 Hou, J. (2023). Distinct mechanisms of dysfunctional antigen-presenting DCs and monocytes by single-cell sequencing in multiple myeloma. Cancer Science, 114(7), 2750\u20132760. https:\/\/doi.org\/10.1111\/cas.15800","DOI":"10.1111\/cas.15800"},{"key":"6241_CR100","doi-asserted-by":"publisher","unstructured":"Jelinek, T., Zihala, D., Sevcikova, T., Anilkumar Sithara, A., Kapustova, V., Sahinbegovic,H.,\u2026 Hajek, R. (2024). Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors. Leukemia, 38(6), 1323\u20131333. https:\/\/doi.org\/10.3324\/haematol.2023.283062https:\/\/doi.org\/10.1038\/s41375-024-02206-w","DOI":"10.3324\/haematol.2023.283062"},{"key":"6241_CR101","doi-asserted-by":"publisher","unstructured":"Favaloro, J., Bryant, C. E., Abadir, E., Gardiner, S., Yang, S., King, T.,\u2026 Ho,P. J. (2023). Single cell analysis of the CD8\u2009+\u2009T-cell compartment in multiple myeloma reveals disease specific changes are chiefly restricted to a CD69- subset suggesting potent cytotoxic effectors exist within the tumor bed. Haematologica, 109(4), 1220\u20131232. https:\/\/doi.org\/10.3324\/haematol.2023.283062","DOI":"10.3324\/haematol.2023.283062"},{"key":"6241_CR102","doi-asserted-by":"publisher","unstructured":"Botta, C., P\u00e9rez Ruiz, C., Goicoechea, I., Puig, N., Cedena, M., Cordon, L.,\u2026 Paiva,B. (2019). Single-Cell Characterization of Multiple Myeloma (MM) Immune Microenvironment Identifies CD27-negative T cells as Potential Tumor-Reactive Lymphocytes. Clinical Lymphoma Myeloma and Leukemia, 19, e351\u2013e352. https:\/\/doi.org\/10.1016\/j.clml.2019.09.581","DOI":"10.1016\/j.clml.2019.09.581"},{"issue":"12","key":"6241_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","volume":"50","author":"P Darvin","year":"2018","unstructured":"Darvin P, Toor SM, Nair S, V., Elkord E (2018) Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp Mol Med 50(12):1\u201311. https:\/\/doi.org\/10.1038\/s12276-018-0191-1","journal-title":"Exp Mol Med"},{"key":"6241_CR104","doi-asserted-by":"publisher","unstructured":"Da Vi\u00e0, M. C., Dietrich, O., Truger, M., Arampatzi, P., Duell, J., Heidemeier, A.,\u2026 Rasche, L. (2021). Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma. Nature Medicine, 27(4), 616\u2013619. https:\/\/doi.org\/10.1038\/s41591-021-01245-5","DOI":"10.1038\/s41591-021-01245-5"},{"key":"6241_CR105","doi-asserted-by":"publisher","unstructured":"Dufva, O., Gandolfi, S., Huuhtanen, J., Dashevsky, O., Du\u00e0n, H., Saeed, K.,\u2026 Mustjoki,S. (2023). Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers. Immunity, 56(12), 2816\u20132835.e13. https:\/\/doi.org\/10.1016\/j.immuni.2023.11.008","DOI":"10.1016\/j.immuni.2023.11.008"},{"key":"6241_CR106","doi-asserted-by":"publisher","unstructured":"Yao, L., Wang, T., Kazuhiro, S., Jayasinghe, R. G., Pilcher, W., Gonzalez-Kozlova,E.,\u2026 Ding, L. (2021). Single-Cell RNA-Seq Analysis of CD138-Depleted Bone Marrow Samples Reveals Genetic Alterations and Disease Progression Correlate with Tumor and Bone Marrow Immune Microenvironment in the Mmrf Commpass Study. Blood, 138(Supplement 1), 2691\u20132691. https:\/\/doi.org\/10.1182\/blood-2021-154081","DOI":"10.1182\/blood-2021-154081"},{"key":"6241_CR107","doi-asserted-by":"publisher","unstructured":"Yao, L., Jayasinghe, R. G., Lee, B. H., Bhasin, S. S., Pilcher, W., Doxie, D. B.,\u2026 Ding, L. (2022). Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis. Cancer Research Communications, 2(10), 1255\u20131265. https:\/\/doi.org\/10.1158\/2767-9764.CRC-22-0022","DOI":"10.1158\/2767-9764.CRC-22-0022"},{"key":"6241_CR108","doi-asserted-by":"publisher","unstructured":"Li, X., Chen, M., Wan, Y., Zhong, L., Han, X., Chen, X.,\u2026 Hou, J. (2022). Single-cell transcriptome profiling reveals the key role of ZNF683 in natural killer cell exhaustion in multiple myeloma. Clinical and Translational Medicine, 12(10), e1065. https:\/\/doi.org\/10.1002\/ctm2.1065","DOI":"10.1002\/ctm2.1065"},{"key":"6241_CR109","doi-asserted-by":"publisher","unstructured":"Wan, Y., Jiang, J., Chen, M., Han, X., Zhong, L., Xiao, F.,\u2026 Hou, J. (2023). Unravelling the imbalanced Th17-like cell differentiation by single-cell RNA sequencing in multiple myeloma. International Immunopharmacology, 124(Pt A), 110852. https:\/\/doi.org\/10.1016\/j.intimp.2023.110852","DOI":"10.1016\/j.intimp.2023.110852"},{"key":"6241_CR110","doi-asserted-by":"publisher","unstructured":"Coffey, D. G., Maura, F., Gonzalez-Kozlova, E., Diaz-Mejia, J. J., Luo, P., Zhang,Y.,\u2026 Landgren, O. (2023). Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma. Nature Communications, 14(1), 5335. https:\/\/doi.org\/10.1038\/s41467-023-40966-8","DOI":"10.1038\/s41467-023-40966-8"},{"key":"6241_CR111","doi-asserted-by":"publisher","unstructured":"Meng, L., Tang, Q., Zhao, J., Wang, Z., Wei, L., Wei, Q.,\u2026 Song, J. (2021). S100A9 Derived From Myeloma Associated Myeloid Cells Promotes TNFSF13B\/TNFRSF13B-Dependent Proliferation and Survival of Myeloma Cells. Frontiers in Oncology, 11, 691705. https:\/\/doi.org\/10.3389\/fonc.2021.691705","DOI":"10.3389\/fonc.2021.691705"},{"key":"6241_CR112","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.2147\/JIR.S452062","volume":"17","author":"X Long","year":"2024","unstructured":"Long X, Li F, Tang S, Liu J, Fu Y, Feng Y (2024) scRNA-Seq and bulk-seq analysis identifies S100A9 plasma cells as a potentially effective Immunotherapeutic Agent for multiple myeloma. J Inflamm Res 17:1527\u20131548. https:\/\/doi.org\/10.2147\/JIR.S452062","journal-title":"J Inflamm Res"},{"key":"6241_CR113","doi-asserted-by":"publisher","unstructured":"de Jong, M. M. E., Kellermayer, Z., Papazian, N., Tahri, S., Hofste Op Bruinink,D., Hoogenboezem, R.,\u2026 Cupedo, T. (2021). The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape. Nature Immunology, 22(6), 769\u2013780. https:\/\/doi.org\/10.1038\/s41590-021-00931-3","DOI":"10.1038\/s41590-021-00931-3"},{"key":"6241_CR114","doi-asserted-by":"publisher","unstructured":"J, X., P, L., Y, W., J, L., B, X., J, Z.,\u2026 P, L. (2024). The role of proliferating stem-like plasma cells in relapsed or refractory multiple myeloma: Insights from single-cell RNA sequencing and proteomic analysis. British journal of haematology, 205(3), 1031\u20131043. https:\/\/doi.org\/10.1111\/bjh.19486","DOI":"10.1111\/bjh.19486"},{"issue":"52","key":"6241_CR115","doi-asserted-by":"publisher","first-page":"e32539","DOI":"10.1097\/MD.0000000000032539","volume":"101","author":"Y Xiang","year":"2022","unstructured":"Xiang Y, Xiang P, Zhang L, Li Y, Zhang J (2022) A narrative review for platelets and their RNAs in cancers: new concepts and clinical perspectives. Medicine 101(52):e32539. https:\/\/doi.org\/10.1097\/MD.0000000000032539","journal-title":"Medicine"},{"key":"6241_CR116","doi-asserted-by":"publisher","unstructured":"Gudgeon, N., Giles, H., Bishop, E. L., Fulton-Ward, T., Escribano-Gonzalez, C., Munford,H.,\u2026 Dimeloe, S. (2023). Uptake of long-chain fatty acids from the bone marrow suppresses CD8\u2009+\u2009T-cell metabolism and function in multiple myeloma. Blood Advances, 7(20), 6035\u20136047. https:\/\/doi.org\/10.1182\/bloodadvances.2023009890","DOI":"10.1182\/bloodadvances.2023009890"},{"issue":"1","key":"6241_CR117","doi-asserted-by":"publisher","first-page":"113643","DOI":"10.1016\/j.celrep.2023.113643","volume":"43","author":"J Hesse","year":"2024","unstructured":"Hesse J, Steckel B, Dieterich P, Aydin S, Deussen A, Schrader J (2024) Intercellular crosstalk shapes purinergic metabolism and signaling in cancer cells. Cell Rep 43(1):113643. https:\/\/doi.org\/10.1016\/j.celrep.2023.113643","journal-title":"Cell Rep"},{"key":"6241_CR118","doi-asserted-by":"publisher","unstructured":"Borsi, E., Vigliotta, I., Poletti, A., Mazzocchetti, G., Solli, V., Zazzeroni, L.,\u2026 Terragna, C. (2024). Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients. Cells, 13(8), 657. https:\/\/doi.org\/10.3390\/cells13080657","DOI":"10.3390\/cells13080657"},{"key":"6241_CR119","doi-asserted-by":"publisher","unstructured":"Frede, J., Anand, P., Sotudeh, N., Pinto, R. A., Nair, M. S., Stuart, H.,\u2026 Lohr,J. G. (2021). Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma. Nature Cell Biology, 23(11), 1199\u20131211. https:\/\/doi.org\/10.1038\/s41556-021-00766-y","DOI":"10.1038\/s41556-021-00766-y"},{"key":"6241_CR120","doi-asserted-by":"publisher","unstructured":"Cho, H., Kim, K. H., Lee, H., Kim, C. G., Chung, H., Choi, Y. S.,\u2026 Kim, J. S. (2021).Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 27(10), 2947\u20132958. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-3418","DOI":"10.1158\/1078-0432.CCR-20-3418"},{"key":"6241_CR121","doi-asserted-by":"publisher","unstructured":"Bessonneau-Gaborit, V., Cruard, J., Guerin-Charbonnel, C., Derrien, J., Alberge,J.-B., Douillard, E.,\u2026 Minvielle, S. (2023). Exploring the impact of dexamethasone on gene regulation in myeloma cells. Life Science Alliance, 6(9), e202302195. https:\/\/doi.org\/10.26508\/lsa.202302195","DOI":"10.26508\/lsa.202302195"},{"key":"6241_CR122","doi-asserted-by":"publisher","unstructured":"Waldschmidt, J. M., Kloeber, J. A., Anand, P., Frede, J., Kokkalis, A., Dimitrova,V.,\u2026 Lohr, J. G. (2021). Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 27(23), 6432\u20136444. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-2040","DOI":"10.1158\/1078-0432.CCR-21-2040"},{"key":"6241_CR123","doi-asserted-by":"publisher","unstructured":"Frede, J., Anand, P., Vijaykumar, T., Waldschmidt, J. M., Nair, M. S., Potdar, S.,\u2026 Lohr, J. (2019). Defining the differentiation states of multiple myeloma at single cell resolution \u2013 Identifying opportunities for immunotherapy. Clinical Lymphoma Myeloma and Leukemia, 19(10, Supplement), e65. https:\/\/doi.org\/10.1016\/j.clml.2019.09.102","DOI":"10.1016\/j.clml.2019.09.102"},{"key":"6241_CR124","doi-asserted-by":"publisher","unstructured":"Cohen, Y. C., Zada, M., Wang, S.-Y., Bornstein, C., David, E., Moshe, A.,\u2026 Amit,I. (2021). Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing. Nature medicine, 27(3), 491\u2013503. https:\/\/doi.org\/10.1038\/s41591-021-01232-w","DOI":"10.1038\/s41591-021-01232-w"},{"key":"6241_CR125","doi-asserted-by":"publisher","unstructured":"Poos, A. M., Prokoph, N., Przybilla, M. J., Mallm, J.-P., Steiger, S., Seufert, I.,\u2026 Weinhold, N. (2023). Resolving therapy resistance mechanisms in multiple myeloma by multi-omics subclone analysis. Blood, 142(19), 1633\u20131646. https:\/\/doi.org\/10.1182\/blood.2023019758","DOI":"10.1182\/blood.2023019758"},{"key":"6241_CR126","doi-asserted-by":"publisher","unstructured":"C, B., C, P., M, L., N, P., Mt, C., R, T.,\u2026 B, P. (2023). Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance. Nature communications, 14(1), 5825. https:\/\/doi.org\/10.1038\/s41467-023-41562-6","DOI":"10.1038\/s41467-023-41562-6"},{"key":"6241_CR127","doi-asserted-by":"publisher","unstructured":"Masuda, T., Haji, S., Nakashima, Y., Tsuda, M., Kimura, D., Takamatsu, A.,\u2026 Ogawa,Y. (2022). Identification of a drug-response gene in multiple myeloma through longitudinal single-cell transcriptome sequencing. iScience, 25(8), 104781. https:\/\/doi.org\/10.1016\/j.isci.2022.104781","DOI":"10.1016\/j.isci.2022.104781"},{"key":"6241_CR128","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1182\/blood-2018-99-117482","volume":"132","author":"P Neri","year":"2018","unstructured":"Neri P, Maity R, McCulloch S, Duggan P, Jimenez-Zepeda V, Tay J, Bahlis N (2018) Identification of specificity groups in Myeloma patients T cell receptor (TCR) repertoire through single cell TCR sequencing. Blood 132:4459\u20134459. https:\/\/doi.org\/10.1182\/blood-2018-99-117482","journal-title":"Blood"},{"key":"6241_CR129","doi-asserted-by":"publisher","unstructured":"Grieb, N., Sia, J., Scolnick, J. A., Cordes, S., Kloetzer, C., Heyn, S.,\u2026 Merz,M. (2022). Single-Cell Multi-Omics of Peripheral Blood Reveals Tiding and Evolution of Responsive and Resistant Clones upon Daratumumab-Based Treatments in Multiple Myeloma and Plasma Cell Leukemia. Blood, 140(Supplement 1), 4207\u20134208. https:\/\/doi.org\/10.1182\/blood-2022-166241","DOI":"10.1182\/blood-2022-166241"},{"key":"6241_CR130","doi-asserted-by":"publisher","unstructured":"Gooding, S., Bjorklund, C. C., Amatangelo, M., Ren, Y., Marella, M., Couto, S.,\u2026Thakurta, A. (2018). Single Cell Analysis of Acquired Pomalidomide-Resistance in Multiple Myeloma Cell Lines Reveals Distinct Subclonal Cereblon Mutations and Gene Expression Heterogeneity. Blood, 132(Supplement 1), 2648\u20132648. https:\/\/doi.org\/10.1182\/blood-2018-99-112644","DOI":"10.1182\/blood-2018-99-112644"},{"key":"6241_CR131","doi-asserted-by":"publisher","unstructured":"Amatangelo, M., Van Oekelen, O., Rahman, A. H., Lagana, A., Gooding, S., Avet-Loiseau,H.,\u2026 Parekh, S. (2019). Multidimensional Single Cell Analysis Shows Increased T\/NK Cell Subsets in Both Blood and Bone Marrow of Iberdomide (CC-220) Treated Relapsed\/Refractory Multiple Myeloma Patients. Blood, 134(Supplement_1), 1775\u20131775. https:\/\/doi.org\/10.1182\/blood-2019-126146","DOI":"10.1182\/blood-2019-126146"},{"key":"6241_CR132","doi-asserted-by":"publisher","unstructured":"Maura, F., Boyle, E. M., Coffey, D., Maclachlan, K., Gagler, D., Diamond, B.,\u2026 Landgren,O. (2023). Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens. Nature Cancer, 4(12), 1660\u20131674. https:\/\/doi.org\/10.1038\/s43018-023-00657-1","DOI":"10.1038\/s43018-023-00657-1"},{"key":"6241_CR133","doi-asserted-by":"publisher","unstructured":"Rodriguez-Marquez, P., Calleja-Cervantes, M. E., Serrano, G., Oliver-Caldes, A.,Palacios-Berraquero, M. L., Martin-Mallo, A.,\u2026 Prosper, F. (2022). CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome. Science Advances, 8(39), eabo0514. https:\/\/doi.org\/10.1126\/sciadv.abo0514","DOI":"10.1126\/sciadv.abo0514"},{"key":"6241_CR134","doi-asserted-by":"publisher","unstructured":"Kropivsek, K., Kachel, P., Goetze, S., Wegmann, R., Festl, Y., Severin, Y.,\u2026 Snijder,B. (2023). Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma. Nature Cancer, 4(5), 734\u2013753. https:\/\/doi.org\/10.1038\/s43018-023-00544-9","DOI":"10.1038\/s43018-023-00544-9"},{"key":"6241_CR135","doi-asserted-by":"publisher","first-page":"1278749","DOI":"10.3389\/fimmu.2023.1278749","volume":"14","author":"Y Xia","year":"2023","unstructured":"Xia Y, Zhao Q, Shen X, Jin Y, Wang J, Zhu J, Chen L (2023) Single-cell transcriptomic atlas throughout anti-BCMA CAR-T therapy in patients with multiple myeloma. Front Immunol 14:1278749. https:\/\/doi.org\/10.3389\/fimmu.2023.1278749","journal-title":"Front Immunol"},{"key":"6241_CR136","doi-asserted-by":"publisher","unstructured":"Lee, H., Ahn, S., Maity, R., Leblay, N., Ziccheddu, B., Truger, M.,\u2026 Bahlis, N.J. (2023). Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma. Nature Medicine, 29(9), 2295\u20132306. https:\/\/doi.org\/10.1038\/s41591-023-02491-5","DOI":"10.1038\/s41591-023-02491-5"},{"key":"6241_CR137","doi-asserted-by":"publisher","unstructured":"Nadeem, O., Aranha, M. P., Redd, R., Timonian, M., Magidson, S., Lightbody, E. D.,\u2026 Ghobrial, I. M. (2024). Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone. medRxiv: The Preprint Server for Health Sciences, 2024.04.19.24306082. https:\/\/doi.org\/10.1101\/2024.04.19.24306082","DOI":"10.1101\/2024.04.19.24306082"},{"key":"6241_CR138","doi-asserted-by":"publisher","unstructured":"Jang, J. S., Li, Y., Mitra, A. K., Bi, L., Abyzov, A., van Wijnen, A. J.,\u2026 Jen,J. (2019). Molecular signatures of multiple myeloma progression through single cell RNA-Seq. Blood Cancer Journal, 9(1), 2. https:\/\/doi.org\/10.1038\/s41408-018-0160-x","DOI":"10.1038\/s41408-018-0160-x"},{"key":"6241_CR139","doi-asserted-by":"publisher","unstructured":"Xu, J., Wang, Y., Wei, Z., Zhuang, J., Li, J., Sun, Y.,\u2026 Liu, P. (2021). Single-Cell Transcriptomes Combining with Consecutive Genomics Reveal Clonal Evolution and Gene Regulatory Networks in Relapsed and Refractory Multiple Myeloma. Frontiers in Cell and Developmental Biology, 9, 794144. https:\/\/doi.org\/10.3389\/fcell.2021.794144","DOI":"10.3389\/fcell.2021.794144"},{"issue":"1","key":"6241_CR140","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s12935-021-02190-6","volume":"21","author":"Z Zeng","year":"2021","unstructured":"Zeng Z, Lin J, Zhang K, Guo X, Zheng X, Yang A, Chen J (2021) Single cell RNA-seq data and bulk gene profiles reveal a novel signature of disease progression in multiple myeloma. Cancer Cell Int 21(1):511. https:\/\/doi.org\/10.1186\/s12935-021-02190-6","journal-title":"Cancer Cell Int"},{"key":"6241_CR141","doi-asserted-by":"publisher","unstructured":"Zhong, L., Hao, P., Zhang, Q., Jiang, T., Li, H., Xiao, J.,\u2026 Gong, B. (2022). Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myeloma (MM). eLife, 11, e75340. https:\/\/doi.org\/10.7554\/eLife.75340","DOI":"10.7554\/eLife.75340"},{"key":"6241_CR142","doi-asserted-by":"publisher","unstructured":"Zhang, W., Wu, C., Geng, S., Wang, J., Yan, C., Zhang, X.,\u2026 Jing, H. (2023). FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma. Aging, 15(9), 3644\u20133677. https:\/\/doi.org\/10.18632\/aging.204697","DOI":"10.18632\/aging.204697"},{"key":"6241_CR143","doi-asserted-by":"publisher","unstructured":"Li, J.-R., Arsang-Jang, S., Cheng, Y., Sun, F., D\u2019Souza, A., Dhakal, B.,\u2026 Cheng,C. (2024). Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing. Blood Cancer Journal, 14(1), 38. https:\/\/doi.org\/10.1038\/s41408-024-01024-8","DOI":"10.1038\/s41408-024-01024-8"},{"issue":"1","key":"6241_CR144","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10238-024-01322-2","volume":"24","author":"J Zhao","year":"2024","unstructured":"Zhao J, Wang X, Zhu H, Wei S, Zhang H, Ma L, Zhu W (2024) Exploring natural killer cell-related biomarkers in multiple myeloma: a novel nature killer cell-related model predicting prognosis and immunotherapy response using single-cell study. Clin Experimental Med 24(1):79. https:\/\/doi.org\/10.1007\/s10238-024-01322-2","journal-title":"Clin Experimental Med"},{"issue":"12","key":"6241_CR145","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.3390\/biom12121855","volume":"12","author":"J Zhao","year":"2022","unstructured":"Zhao J, Wang X, Zhu H, Wei S, Zhang H, Ma L, He P (2022) Integrative analysis of bulk RNA-Seq and single-cell RNA-Seq unveils novel prognostic biomarkers in multiple myeloma. Biomolecules 12(12):1855. https:\/\/doi.org\/10.3390\/biom12121855","journal-title":"Biomolecules"},{"key":"6241_CR146","doi-asserted-by":"publisher","unstructured":"Lohr, J. G., Kim, S., Gould, J., Knoechel, B., Drier, Y., Cotton, M. J.,\u2026 Golub,T. R. (2016). Genetic interrogation of circulating multiple myeloma cells at single-cell resolution. Science Translational Medicine, 8(363), 363ra147. https:\/\/doi.org\/10.1126\/scitranslmed.aac7037","DOI":"10.1126\/scitranslmed.aac7037"},{"key":"6241_CR147","doi-asserted-by":"publisher","unstructured":"Melnekoff, D., Lagana, A., Hamou, W., Allette, K., Beno, I., Leshchenko, V.,\u2026 Parekh,S. (2017). Single-Cell RNA Sequencing Reveals Distinct Transcriptomic Profiles of Multiple Myeloma with Implications for Personalized Medicine. Blood, 130, 62. https:\/\/doi.org\/10.1182\/blood.V130.Suppl_1.62.62","DOI":"10.1182\/blood.V130.Suppl_1.62.62"},{"key":"6241_CR148","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.omtm.2023.05.014","volume":"29","author":"M Okada","year":"2023","unstructured":"Okada M, Shimizu K, Nakazato H, Yamasaki S, Fujii S-I (2023) Detection of mutant antigen-specific T cell receptors against multiple myeloma for T cell engineering. Mol Therapy Methods Clin Dev 29:541\u2013555. https:\/\/doi.org\/10.1016\/j.omtm.2023.05.014","journal-title":"Mol Therapy Methods Clin Dev"},{"key":"6241_CR149","doi-asserted-by":"publisher","unstructured":"Ng, M. H., Lau, K.-M., Chan, N. C., Kwan, J. S., Xia, J. T., Cheng, C.-K.,\u2026 Chan,N. P. (2019). Single Cell Rna-Seq Revealed a Rare ITGA2 Expressing Cell Subpopulation with Distinct Cancer Stem Cell Marker Signature in Multiple Myeloma. HemaSphere, 3(S1), 239. https:\/\/doi.org\/10.1097\/01.HS9.0000560580.26057.6e","DOI":"10.1097\/01.HS9.0000560580.26057.6e"},{"key":"6241_CR150","doi-asserted-by":"publisher","unstructured":"Schavgoulidze, A., Corre, J., Samur, M. K., Mazzotti, C., Pavageau, L., Perrot, A.,\u2026 Avet-Loiseau, H. (2024). RAS\/RAFlandscape in monoclonal plasma cell conditions.Blood, blood.2023022295. https:\/\/doi.org\/10.1182\/blood.2023022295","DOI":"10.1182\/blood.2023022295"},{"key":"6241_CR151","doi-asserted-by":"publisher","unstructured":"Durand, R., Descamps, G., Bellanger, C., Dousset, C., Ma\u00efga, S., Alberge, J.-B.,\u2026 Pellat-Deceunynck, C. (2024). A p53 score derived from TP53 CRISPR\/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics. Blood, 143(13), 1242\u20131258. https:\/\/doi.org\/10.1182\/blood.2023021581","DOI":"10.1182\/blood.2023021581"},{"key":"6241_CR152","doi-asserted-by":"publisher","unstructured":"Perrin, J., Capitao, M., Allard, M., Chouin, N., Gouard, S., Marionneau-Lambot, S.,\u2026 Guilloux, Y. (2022). Targeted Alpha Particle Therapy Remodels the Tumor Microenvironment and Improves Efficacy of Immunotherapy. International Journal of Radiation Oncology, Biology, Physics, 112(3), 790\u2013801. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.10.013","DOI":"10.1016\/j.ijrobp.2021.10.013"},{"key":"6241_CR153","doi-asserted-by":"publisher","unstructured":"Cheloni, G., Karagkouni, D., Torres, D., Chung, D. J., Shah, N., Callander, N. S.,\u2026 Avigan, D. (2023). Dendritic cell\/myeloma fusion vaccine with lenalidomide maintenance following autologous hematopoietic cell transplant induced T cell activation and expansion.Cancer Research, 83(7_Supplement), 6785\u20136785. https:\/\/doi.org\/10.1158\/1538-7445.AM2023-6785","DOI":"10.1158\/1538-7445.AM2023-6785"},{"key":"6241_CR154","doi-asserted-by":"publisher","unstructured":"Du, J., Wei, R., Jiang, S., Jiang, H., Li, L., Qiang, W.,\u2026 Fu, W. (2022). CAR-T cell therapy targeting B cell maturation antigen is effective for relapsed\/refractory multiple myeloma, including cases with poor performance status. American journal of hematology, 97(7), 933\u2013941. https:\/\/doi.org\/10.1002\/ajh.26583","DOI":"10.1002\/ajh.26583"},{"issue":"1","key":"6241_CR155","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41588-024-01997-z","volume":"57","author":"Y Liu","year":"2025","unstructured":"Liu Y, Carbonetto P, Willwerscheid J, Oakes SA, Macleod KF, Stephens M (2025) Dissecting tumor transcriptional heterogeneity from single-cell RNA-seq data by generalized binary covariance decomposition. Nat Genet 57(1):263\u2013273. https:\/\/doi.org\/10.1038\/s41588-024-01997-z","journal-title":"Nat Genet"},{"issue":"1","key":"6241_CR156","doi-asserted-by":"publisher","first-page":"9468","DOI":"10.1038\/s41467-024-53666-8","volume":"15","author":"A Goeva","year":"2024","unstructured":"Goeva A, Dolan M-J, Luu J, Garcia E, Boiarsky R, Gupta RM, Macosko E (2024) HiDDEN: a machine learning method for detection of disease-relevant populations in case-control single-cell transcriptomics data. Nat Commun 15(1):9468. https:\/\/doi.org\/10.1038\/s41467-024-53666-8","journal-title":"Nat Commun"},{"key":"6241_CR157","doi-asserted-by":"publisher","first-page":"39921","DOI":"10.1038\/srep39921","volume":"7","author":"P-Y Tung","year":"2017","unstructured":"Tung P-Y, Blischak JD, Hsiao CJ, Knowles DA, Burnett JE, Pritchard JK, Gilad Y (2017) Batch effects and the effective design of single-cell gene expression studies. Sci Rep 7:39921. https:\/\/doi.org\/10.1038\/srep39921","journal-title":"Sci Rep"},{"key":"6241_CR158","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13059-019-1850-9","volume":"21","author":"HTN Tran","year":"2020","unstructured":"Tran HTN, Ang KS, Chevrier M, Zhang X, Lee NYS, Goh M, Chen J (2020) A benchmark of batch-effect correction methods for single-cell RNA sequencing data. Genome Biol 21:12. https:\/\/doi.org\/10.1186\/s13059-019-1850-9","journal-title":"Genome Biol"},{"key":"6241_CR159","doi-asserted-by":"publisher","unstructured":"Luecken, M. D., B\u00fcttner, M., Chaichoompu, K., Danese, A., Interlandi, M., Mueller,M. F.,\u2026 Theis, F. J. (2022). Benchmarking atlas-level data integration in single-cell genomics. Nature Methods, 19(1), 41\u201350. https:\/\/doi.org\/10.1038\/s41592-021-01336-8","DOI":"10.1038\/s41592-021-01336-8"},{"issue":"1","key":"6241_CR160","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41467-023-36635-5","volume":"14","author":"X Yu","year":"2023","unstructured":"Yu X, Xu X, Zhang J, Li X (2023) Batch alignment of single-cell transcriptomics data using deep metric learning. Nat Commun 14(1):960. https:\/\/doi.org\/10.1038\/s41467-023-36635-5","journal-title":"Nat Commun"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06241-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06241-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06241-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T15:20:06Z","timestamp":1743866406000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06241-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":160,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["6241"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06241-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}